This protocol addresses the acute phase of Chikungunya virus disease occurring in a pregnant patient. The presence of pregnancy significantly shapes both the choice of symptomatic therapy and the need for specialist involvement.
Symptomatic management is the cornerstone, with careful attention to which analgesic-antipyretic agents are appropriate in pregnancy — a key distinction applies between permitted and contraindicated options in this population.
Full regimen, clinical algorithm, and obstetric coordination criteria available in the complete protocol →